Home » Topics » Regulatory » Patents

Patents
RSS

Cocrystal Pharma introduces NS5B inhibitors

Oct. 11, 2016

JW Pharmaceutical reports desfesoterodine derivatives

Oct. 10, 2016

Intra-Cellular Therapies describes NET and/or SERT ligands

Oct. 10, 2016

Roche develops BACE1 inhibitors

Oct. 10, 2016

Toray Industries discloses analgesic agents

Oct. 10, 2016

Novartis patents FGFR-4 inhibitors

Oct. 10, 2016

Hokkaido University presents oxidative stress-induced cell death inhibitors

Oct. 7, 2016

Mironid develops PDE4 activators

Oct. 7, 2016

Shanghai Yingli Pharmaceutical describes URAT1 inhibitors

Oct. 7, 2016

Akarna Therapeutics discloses FXR agonists

Oct. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...